Pathological Complete Response with Neoadjuvant Trastuzumab, Pertuzumab, and Chemotherapy Followed by Modified Radical Mastectomy in a Patient with HER2-Positive Occult Breast Cancer

Chunchun Chen; Jinhai Zhu; Chao Zhang; Lin Wang; Yulong Li; Mingnan Du

doi:10.12659/AJCR.943936

19 September 2024 : Case report China

Pathological Complete Response with Neoadjuvant Trastuzumab, Pertuzumab, and Chemotherapy Followed by Modified Radical Mastectomy in a Patient with HER2-Positive Occult Breast Cancer

Challenging differential diagnosis, Unusual or unexpected effect of treatment

Chunchun Chen^1ABCE, Jinhai Zhu^1BCDE*, Chao Zhang^1CDE, Lin Wang^1DE, Yulong Li^1BF, Mingnan Du^1BEF

DOI: 10.12659/AJCR.943936

Am J Case Rep 2024; 25:e943936

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. A mammography examination on February 15, 2022 revealed abnormal lymph nodes in the left axilla (red arrow) in the absence of a breast lesion.

Back to the Article

Pathological Complete Response with Neoadjuvant Trastuzumab, Pertuzumab, and Chemotherapy Followed by Modified Radical Mastectomy in a Patient with HER2-Positive Occult Breast Cancer

Your Privacy